Quris

News

AI innovator Quris seed funding grows to $37 million

Quris, an artificial intelligence (AI) innovator in the pharmaceutical arena, has secured an additional $9 million in seed funding, expanding its

News

Rare disease, repurposing and the role of AI

Changing Faces: pharma supplier, DTx, and non-profit hires f...

A number of pharma-adjacent tech firms and non-profits announced personnel news in the month of November. We’ve rounded up some highlights below.

News

Merck will assess Quris' AI 'patient-on-a-chip' drug safety ...

German drugmaker Merck KGaA has reached an agreement to pilot an artificial intelligence platform developed by Quris that aims to identify potential safety problems with new therapeutic can

AI innovator Quris seed funding grows to $37 million

Changing Faces: pharma supplier, DTx, and non-profit hires f...

Merck will assess Quris' AI 'patient-on-a-chip' drug safety ...

FDA clears Viridian's Tepezza rival for thyroid eye disease

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks